Covidien’s (COV) Stellarex DCB Gets CE Mark Approval
Covidien plc ’s ( COV ) Stellarex drug-coated balloon (DCB) has received the CE Mark approval in Europe. Designed to treat patients with peripheral arterial disease (PAD), Stellarex DCB is part of Covidien’s vascular product line. […]